Form 990 for tax year 2025
Filed by SANSUM DIABETES RESEARCH INSTITUTE.
Totals
- Total revenue
- $6,303,337
- Total expenses
- $7,162,681
- Contributions and grants received
- $2,934,028
- Grants paid
- $0
- Program service revenue
- $2,087,229
- Investment income
- $1,412,044
- Other revenue
- -$129,964
- Total assets, end of year
- $28,805,606
- Total liabilities, end of year
- $4,051,624
- Net assets or fund balances, end of year
- $24,753,982
- Program services expenses (Part IX)
- $5,282,012
- Management and general expenses
- $1,034,974
- Fundraising expenses
- $845,695
- Program service expenses (Part III)
- $5,282,012
Program services were 73.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1c · Fundraising events
$465,074
-
1f · All other contributions, gifts and grants
$2,468,954
-
1g · Noncash contributions included above
$33,311
-
2a · Program service revenue: Patient Care Fees
total $50,045 · related or exempt $50,045
-
2b · Program service revenue: Research Contracts
total $2,037,184 · related or exempt $2,037,184
-
3 · Investment income
total $401,378 · excluded $401,378
-
4 · Income from investment of tax-exempt bond proceeds
total $0
-
5 · Royalties
total $0
-
6d · Net rental income or loss
total $0
-
7a · Gross sales of assets other than inventory
securities $4,687,771
-
7b · Less cost or other basis and sales expenses
securities $3,620,847 · other assets $56,258
-
7c · Gain or loss
securities $1,066,924 · other assets -$56,258
-
7d · Net gain or loss
total $1,010,666 · related or exempt $1,010,666
-
8a · Fundraising events: gross income
$45,750
-
8a · Fundraising events: contributions included on line 1c
$465,074
-
8b · Fundraising events: direct expenses
$175,890
-
8c · Net income from fundraising events
total -$130,140 · excluded -$130,140
-
9c · Net income from gaming
total $0
-
10c · Net income from sales of inventory
total $0
-
11a · Other revenue: Other
total $176 · related or exempt $176
-
11e · Other revenue, total
$176
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $0
-
2 · Grants to domestic individuals
total $0
-
3 · Grants to foreign organizations and individuals
total $0
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $1,057,915 · program services $519,880 · management and general $255,955 · fundraising $282,080
-
6 · Compensation of disqualified persons
total $0
-
7 · Other salaries and wages
total $3,267,323 · program services $2,871,992 · management and general $245,732 · fundraising $149,599
-
8 · Pension plan contributions
total $93,218 · program services $83,967 · management and general $7,258 · fundraising $1,993
-
9 · Other employee benefits
total $303,146 · program services $231,401 · management and general $49,550 · fundraising $22,195
-
10 · Payroll taxes
total $313,761 · program services $247,935 · management and general $35,042 · fundraising $30,784
-
11a · Fees: management
total $0
-
11b · Fees: legal
total $9,434 · management and general $9,434
-
11c · Fees: accounting
total $27,000 · management and general $27,000
-
11d · Fees: lobbying
total $0
-
11e · Fees: professional fundraising services
total $0
-
11f · Fees: investment management
total $25,268 · management and general $25,268
-
11g · Fees: other
total $1,088,222 · program services $569,714 · management and general $290,537 · fundraising $227,971
-
12 · Advertising and promotion
total $34,415 · program services $6,372 · management and general $1,606 · fundraising $26,437
-
13 · Office expenses
total $98,086 · program services $63,072 · management and general $13,644 · fundraising $21,370
-
14 · Information technology
total $216,008 · program services $141,004 · management and general $30,112 · fundraising $44,892
-
15 · Royalties
total $0
-
16 · Occupancy
total $35,864 · program services $26,009 · management and general $7,183 · fundraising $2,672
-
17 · Travel
total $24,137 · program services $17,917 · management and general $4,526 · fundraising $1,694
-
18 · Travel or entertainment for public officials
total $0
-
19 · Conferences, conventions and meetings
total $46,207 · program services $36,291 · management and general $4,627 · fundraising $5,289
-
20 · Interest
total $0
-
21 · Payments to affiliates
total $0
-
22 · Depreciation, depletion and amortization
total $161,832 · program services $133,121 · management and general $14,672 · fundraising $14,039
-
23 · Insurance
total $79,612 · program services $64,964 · management and general $12,828 · fundraising $1,820
-
24a · Other expenses: Subject Reimbursement
total $207,845 · program services $207,845
-
24b · Other expenses: Lab Supplies
total $55,770 · program services $55,770
-
24c · Other expenses: Campaign Expenses
total $17,618 · program services $4,758 · fundraising $12,860
-
24e · All other expenses
total $0
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $496,358 · end of year $125,700
-
2 · Savings and temporary cash investments
beginning of year $7,773,243 · end of year $2,158,353
-
3 · Pledges and grants receivable
beginning of year $1,704,404 · end of year $1,679,962
-
4 · Accounts receivable
beginning of year $294,184 · end of year $262,369
-
5 · Loans and receivables from officers and key people
end of year $0
-
6 · Loans and receivables from disqualified persons
end of year $0
-
7 · Other notes and loans receivable
beginning of year $600,000 · end of year $600,000
-
8 · Inventories for sale or use
end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $71,227 · end of year $51,175
-
10a · Land, buildings and equipment: cost or other basis
$11,403,191
-
10b · Land, buildings and equipment: accumulated depreciation
$2,016,487
-
10c · Land, buildings and equipment, net
beginning of year $2,134,330 · end of year $9,386,704
-
11 · Investments: publicly traded securities
beginning of year $9,857,957 · end of year $11,186,692
-
12 · Investments: other securities
end of year $0
-
13 · Investments: program-related
end of year $0
-
14 · Intangible assets
end of year $0
-
15 · Other assets
beginning of year $3,613,290 · end of year $3,354,651
-
17 · Accounts payable and accrued expenses
beginning of year $1,078,731 · end of year $1,379,606
-
23 · Secured mortgages and notes payable
end of year $2,626,255
-
25 · Other liabilities
beginning of year $398,042 · end of year $45,763
-
27 · Net assets without donor restrictions
beginning of year $14,361,122 · end of year $13,399,618
-
28 · Net assets with donor restrictions
beginning of year $10,707,098 · end of year $11,354,364
Mission and programs · 2025
Mission
Dedicated to improving the lives of people impacted by diabetes through research, education and care.
-
ResearchClinical Research Type 1 DiabetesSansum Diabetes Research Institute (SDRI) is a nonprofit organization dedicated to improving the lives of people impacted by diabetes through clinical research, education, and specialized patient care. During 2025, SDRI initiated 13 clinical research trials involving 197 individual participants. These studies evaluated new technologies, medications, and treatment approaches intended to improve diabetes management and health outcomes.Research activities included automated insulin delivery systems, continuous glucose monitoring, inhaled insulin therapies, GLP-1 medications, ketone and lactate monitoring, digital health tools, and other emerging diabetes technologies. SDRI collaborated with leading diabetes technology and pharmaceutical companies to conduct research that supports the development of safer and more effective treatments for people living with diabetes.During 2025, SDRI also launched Screen & Support, a community-based type 1 diabetes early detection program. Through autoantibody screening, education, monitoring, and follow-up care, the program identifies children and adults at increased risk for developing type 1 diabetes before symptoms occur. Earlier identification helps reduce the likelihood of diagnosis during diabetic ketoacidosis (DKA), provides families with education and support, and expands access to therapies that may delay progression to insulin-dependent disease. SDRI also continued leading the California Type 1 Diabetes Screening Collaborative to expand early detection efforts throughout California.Clinical Research Type 2 DiabetesSDRI continued research designed to improve treatment options and clinical outcomes for individuals living with type 2 diabetes. During 2025, the SDRI participated in studies evaluating automated insulin delivery systems, continuous glucose monitoring technologies, and emerging therapeutic approaches intended to improve glycemic control while reducing the burden of diabetes management.Research findings contributed to the growing body of evidence supporting advanced diabetes technologies for adults with type 2 diabetes and included participation from diverse populations to improve the applicability of study findings across communities.
Expenses $4,634,525 · Revenue $1,969,111
-
Education and Community OutreachCommunity education is an essential component of SDRI's charitable mission. SDRI provides evidence-based education, peer support, and culturally responsive programs that improve diabetes prevention and self-management.During 2025, SDRI continued Ocho Pasos a la Buena Salud, a Spanish-language diabetes prevention and self-management program led by trained Community Health Workers (Promotoras). The program provides culturally appropriate education on nutrition, physical activity, and diabetes self-management while addressing barriers to healthcare access.SDRI also expanded education and support through One Talk, LADA Talk, diabetes technology training, bilingual support groups, community outreach events, and Back-to-School educational programming. These programs improve diabetes knowledge, increase self-management skills, reduce diabetes-related distress, and strengthen community support for individuals and families affected by diabetes.
Expenses $367,818 · Revenue $68,073
-
Clinical CareSDRI provides specialized outpatient clinical care in diabetes in pregnancy, pediatric diabetes, and adult endocrinology.During 2025, SDRI expanded its Diabetes in Pregnancy Program to preserve access to specialized care following changes in local maternal health services. SDRI assumed responsibility for caring for approximately 100 additional patients, with particular emphasis on serving under-resourced and underrepresented Latina women throughout Santa Barbara County.Clinical services include individualized diabetes management, nutrition counseling, continuous glucose monitoring support, medication management, diabetes education, and coordinated care with obstetric and maternal-fetal medicine providers. SDRI also provides culturally responsive and bilingual services to improve maternal and infant health outcomes.SDRI's pediatric diabetes program provides comprehensive education, technology training, behavioral support, and ongoing clinical care that helps children, adolescents, and families safely manage diabetes and successfully transition to lifelong self-management.
Expenses $279,669 · Revenue $50,045
-
Research InfrastructureDuring 2025, SDRI completed renovation of its 18,000-square-foot research, clinical care, and education center. The renovated facility increased organizational capacity by providing dedicated research suites, expanded clinical space, industry collaboration areas, a teaching kitchen, a DEXA research suite, and community education facilities. These improvements enhance SDRI's ability to conduct clinical research, provide specialized patient care, and deliver diabetes education programs that benefit the community.Summary of Public BenefitThrough its integrated programs in clinical research, specialized clinical care, early detection, education, and community outreach, SDRI advances the early detection, treatment, and management of diabetes while improving access to evidence-based care for children, adults, pregnant individuals, and underserved populations. These activities further SDRIs charitable mission by improving health outcomes, expanding access to specialized services, and advancing diabetes science for the benefit of the public.
As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Elizabeth Thompson
CEO
- Total calculated
- $349,314
- From this org
- $329,755
- From related orgs
- $0
- Other
- $19,559
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $329,755
- Bonus
- not reported
- Other
- not reported
- Deferred
- $16,488
- Nontaxable benefits
- $3,071
- Filer's total
- $349,314
-
Kristin Castorino DO
Research Physician
- Total calculated
- $290,760
- From this org
- $264,433
- From related orgs
- $0
- Other
- $26,327
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $264,433
- Bonus
- not reported
- Other
- not reported
- Deferred
- $13,520
- Nontaxable benefits
- $12,807
- Filer's total
- $290,760
-
Kristen Nelson
Dir Clinical Rese
- Total calculated
- $270,167
- From this org
- $256,529
- From related orgs
- $0
- Other
- $13,638
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $256,529
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $13,638
- Filer's total
- $270,167
-
Dr Andrew Rhinehart
CEO/CMO
- Total calculated
- $237,257
- From this org
- $230,465
- From related orgs
- $0
- Other
- $6,792
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $230,465
- Bonus
- not reported
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $6,792
- Filer's total
- $237,257
-
Kara Hornbuckle
VP Development and Public Affairs
- Total calculated
- $180,584
- From this org
- $168,763
- From related orgs
- $0
- Other
- $11,821
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $168,763
- Bonus
- not reported
- Other
- not reported
- Deferred
- $9,500
- Nontaxable benefits
- $2,321
- Filer's total
- $180,584
-
Sarintha Logan
Clinical Research
- Total calculated
- $178,932
- From this org
- $161,001
- From related orgs
- $0
- Other
- $17,931
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $161,001
- Bonus
- not reported
- Other
- not reported
- Deferred
- $8,172
- Nontaxable benefits
- $9,759
- Filer's total
- $178,932
-
Trisha Purkey
Clinical Research
- Total calculated
- $176,056
- From this org
- $156,913
- From related orgs
- $0
- Other
- $19,143
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $156,913
- Bonus
- not reported
- Other
- not reported
- Deferred
- $7,899
- Nontaxable benefits
- $11,244
- Filer's total
- $176,056
-
Melody Lung
Clinical Research
- Total calculated
- $148,976
- From this org
- $136,826
- From related orgs
- $0
- Other
- $12,150
- Hours/week
- 40
-
Olivia Watt
Mgr Lab/Research
- Total calculated
- $139,105
- From this org
- $130,214
- From related orgs
- $0
- Other
- $8,891
- Hours/week
- 40
-
James Sloan
President
- Total calculated
- $0
- Hours/week
- 4
-
Matthew Rowe CIMA
Vice President
- Total calculated
- $0
- Hours/week
- 2
-
Flint Ogle
Treasurer
- Total calculated
- $0
- Hours/week
- 2
-
Elena Engel
Secretary
- Total calculated
- $0
- Hours/week
- 2
-
Joan Doell Arnold
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Miguel Avila
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Daniel Berger MD
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Anthony Castillo
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Daren Dickerson
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Lindsey Duca PhD
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Lynn Fitzgibbons MD
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Yvette Giller
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Steven Jung Esq
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Norman Kurland
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Robert Nagy MD
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Michael Paskin
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Wendy Thies Sell
Trustee
- Total calculated
- $0
- Hours/week
- 1
-
Mark Wilson
Trustee
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Written employment contract
- 3 · Approval by the board or compensation committee
- 4a · Severance or change-of-control payment
Answered no
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Provenance
- Return type
- form_990
- Tax year
- 2025
- Filed
- 31 August 2026
- IRS schema version
- 2025v4.1
- Source object
- 202612439349300846
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.